[1]CurrentPatentAssignee:KALYPSYS,INC.;KALYPSIS-US2007/135431,2007,A1Locationinpatent:Page/Pagecolumn15;16
1623-92-3
121-63-1
84910-98-5
75157-75-4
192329-90-1
885950-88-9
61837-65-8 | 2,4-Imidazolidinedione, 5-ethyl-5-(4-hydroxyphenyl)-3-methyl- | AA00IAUK | MFCD00142316
62625-29-0 | Cresol red sodium salt | AA00IAZA | MFCD00001618
63388-01-2 | 1-(2-Hydroxyethyl)-1H-benzo[d]imidazol-2(3H)-one | AA00IB4L | MFCD02271217
64289-45-8 | 3-Amino-2,4-dimethylbenzoic acid | AA00IB9P | MFCD20641501
656-53-1 | 4-Methyl-5-thiazolylethyl acetate | AA00IBFH | MFCD00005338
67284-56-4 | Trans-4'-cyano-[1,1'-biphenyl]-4-yl 4-ethylcyclohexanecarboxylate | AA00IBMA | MFCD09751067
68774-77-6 | 8-Chloro-[1,2,4]triazolo[4,3-a]pyrazine | AA00IBSK | MFCD08272086
702664-43-5 | 4-(2,4-Dioxo-1,4-dihydrothieno[3,2-d]pyrimidin-3(2h)-yl)butanoic acid | AA00IBYH | MFCD04063015
720693-08-3 | 4-[(6-Chloropyridin-2-yl)carbonyl]morpholine | AA00IC54 | MFCD16698133
730973-18-9 | ([5-(2-Fluorophenyl)-4-phenyl-4h-1,2,4-triazol-3-yl]thio)acetic acid | AA00IC9X | MFCD04623107
